conference reports
Using urinary microRNA as a potential biomarker for bladder cancer
Monday, 31 May 2010- MicroRNAs are single stranded non-coding RNA molecules 19-25nt in length. They regulate the expression of protein-coding genes at the translational level. Both functional and observation data suggest an...
Edited by: JV
Amsterdam bladder cancer symposium to tackle multidisciplinary management issues
Wednesday, 12 May 2010- Therapy dilemmas, complicated cases and issues in the multidisciplinary management of bladder cancer will be closely examined by international experts at the upcoming one-day international State-of-the-Art...
Edited by: JV
SEER registries: increase in metastatic BC noted in female, white elderly population
Tuesday, 11 May 2010- A group researchers assessed the rate of metastatic bladder cancer at diagnosis in a population-based tumour registry and noted the increase amongst elderly, female Caucasian population. D. Liberman...
Edited by: JV
Multicentre study confirms earlier survival results of vinflunine in bladder cancer therapy
Monday, 10 May 2010- Second line therapy in advanced Transitional Cell Carcinoma of the Urothelium (TCCU) was an unmet medical need up to the approval of vinflunine, a new microtubule inhibitor, in patients (pts) having...
Edited by: JV
Recurrence and progression in patients with bladder tumours treated with BCG
Friday, 30 April 2010- A group of researchers from Madrid, Spain evaluated the prognostic factors of recurrence and progression in patients with carcinoma in situ (CIS) of the bladder treated with intravesical Bacille...
Edited by: JV
15-year outcomes of selective bladder preservation for invasive bladder cancer
Friday, 26 March 2010- Researchers in the US reported long-term outcomes of patients with muscle- invasive bladder cancer treated with combined modality therapy (CMT) (transurethral resection bladder tumour [TURBT], radiation...
Edited by: JV
KTP laser ablation of small, noninvasive TCC of bladder in an outpatient, office setting
Friday, 19 March 2010- Noninvasive transitional cell carcinoma of bladder comprises the majority of bladder cancers. Although this tumour has a low potential for invasion, it does recur and progress.
M. M. Siddiqui and...
Edited by: JV
Issues and trends at International Bladder Cancer Symposium in Amsterdam
Tuesday, 9 March 2010- Leading experts from Europe, North America and other parts of the world will lecture and discuss the latest developments in research, diagnosis and treatment of bladder cancer during the "International...
Ëdited by: JV
Davos: Key messages from lectures on BCa, OAB
Monday, 15 February 2010- The search for biomarkers in bladder cancer and current developments in the of the overactive bladder (OAB) were discussed in the morning session of the third day at the European Urology Forum held...
By Joel Vega
